National Research EBIT

National Research (NRC) currently reports a EBIT of $16M as of September 2026. That compares with $26M in the prior-year period — down 37.7% year over year. That is below the Healthcare sector average of $99B. Use the charts on this page to explore National Research's EBIT history and peer comparisons.

National Research's EBIT decreased from $26M to $16M — a 37.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

National Research's EBIT of $16M is lower than the Healthcare sector average of $99B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

National Research reported $16M in EBIT as of September 2026. That compares with $26M in the prior-year period — down 37.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $99B. From there, open related valuation or income-statement pages for National Research, and consider following NRC for alerts when major investors trade the stock.